Cargando…
Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics
β-lactam antibiotics (BLA) are commonly reported to induce hypersensitivity reactions. However, β-lactam antibiotic-stratified analyses are rare. In the presented study, β-lactam antibiotic associated hypersensitivity reactions were analyzed in the European adverse drug reaction (ADR) database. 923,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822522/ https://www.ncbi.nlm.nih.gov/pubmed/35141466 http://dx.doi.org/10.5414/ALX02189E |
_version_ | 1784646621466722304 |
---|---|
author | Dubrall, Diana Schulz, Maike Schmid, Matthias Sachs, Bernhardt |
author_facet | Dubrall, Diana Schulz, Maike Schmid, Matthias Sachs, Bernhardt |
author_sort | Dubrall, Diana |
collection | PubMed |
description | β-lactam antibiotics (BLA) are commonly reported to induce hypersensitivity reactions. However, β-lactam antibiotic-stratified analyses are rare. In the presented study, β-lactam antibiotic associated hypersensitivity reactions were analyzed in the European adverse drug reaction (ADR) database. 923, 38, 222, and 99 hypersensitivity reports for penicillins and first-, second- and third-generation cephalosporins were reported. Differences with regard to demographical parameters, seriousness and types of hypersensitivity reactions, as well as in the number of hypersensitivity reports per outpatient prescriptions were observed between the different β-lactam antibiotics. The number of ADR reports classified as serious was higher for all generations of cephalosporins compared to penicillins. Additionally, anaphylactic reactions were more often reported for first- and second-generation cephalosporins compared to third-generation cephalosporins and penicillins, while bullous reactions were more often reported for first- and third-generation cephalosporins as opposed to second-generation cephalosporins and penicillins. The observed differences may be caused by differences between β-lactam antibiotics and their routes of administration (oral, intravenous), the patient populations, or the reporting of ADRs. Due to the methodological limitations of ADR database analysis, no conclusions can be drawn whether and to what extent the aforementioned factors influenced our results. |
format | Online Article Text |
id | pubmed-8822522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dustri-Verlag Dr. Karl Feistle |
record_format | MEDLINE/PubMed |
spelling | pubmed-88225222022-02-08 Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics Dubrall, Diana Schulz, Maike Schmid, Matthias Sachs, Bernhardt Allergol Select Research Article β-lactam antibiotics (BLA) are commonly reported to induce hypersensitivity reactions. However, β-lactam antibiotic-stratified analyses are rare. In the presented study, β-lactam antibiotic associated hypersensitivity reactions were analyzed in the European adverse drug reaction (ADR) database. 923, 38, 222, and 99 hypersensitivity reports for penicillins and first-, second- and third-generation cephalosporins were reported. Differences with regard to demographical parameters, seriousness and types of hypersensitivity reactions, as well as in the number of hypersensitivity reports per outpatient prescriptions were observed between the different β-lactam antibiotics. The number of ADR reports classified as serious was higher for all generations of cephalosporins compared to penicillins. Additionally, anaphylactic reactions were more often reported for first- and second-generation cephalosporins compared to third-generation cephalosporins and penicillins, while bullous reactions were more often reported for first- and third-generation cephalosporins as opposed to second-generation cephalosporins and penicillins. The observed differences may be caused by differences between β-lactam antibiotics and their routes of administration (oral, intravenous), the patient populations, or the reporting of ADRs. Due to the methodological limitations of ADR database analysis, no conclusions can be drawn whether and to what extent the aforementioned factors influenced our results. Dustri-Verlag Dr. Karl Feistle 2022-02-03 /pmc/articles/PMC8822522/ /pubmed/35141466 http://dx.doi.org/10.5414/ALX02189E Text en © Dustri-Verlag Dr. K. Feistle https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Dubrall, Diana Schulz, Maike Schmid, Matthias Sachs, Bernhardt Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics |
title | Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics |
title_full | Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics |
title_fullStr | Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics |
title_full_unstemmed | Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics |
title_short | Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics |
title_sort | descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different beta-lactam antibiotics |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822522/ https://www.ncbi.nlm.nih.gov/pubmed/35141466 http://dx.doi.org/10.5414/ALX02189E |
work_keys_str_mv | AT dubralldiana descriptiveanalysisofadversedrugreactionreportsforhypersensitivityreactionsstratifiedinrelationtodifferentbetalactamantibiotics AT schulzmaike descriptiveanalysisofadversedrugreactionreportsforhypersensitivityreactionsstratifiedinrelationtodifferentbetalactamantibiotics AT schmidmatthias descriptiveanalysisofadversedrugreactionreportsforhypersensitivityreactionsstratifiedinrelationtodifferentbetalactamantibiotics AT sachsbernhardt descriptiveanalysisofadversedrugreactionreportsforhypersensitivityreactionsstratifiedinrelationtodifferentbetalactamantibiotics |